Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Julijan, Kabiljo"'
Autor:
Victoria Stary, Ram V. Pandey, Julia List, Lisa Kleissl, Florian Deckert, Julijan Kabiljo, Johannes Laengle, Vasileios Gerakopoulos, Rudolf Oehler, Lukas Watzke, Matthias Farlik, Samuel W. Lukowski, Anne B. Vogt, Georg Stary, Hannes Stockinger, Michael Bergmann, Nina Pilat
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-15 (2024)
Abstract Although γδ T cells are known to participate in immune dysregulation in solid tumors, their relevance to human microsatellite-stable (MSS) colorectal cancer (CRC) is still undefined. Here, using integrated gene expression analysis and T ce
Externí odkaz:
https://doaj.org/article/1b6fc00683304336b4bec35e2139e3b7
Autor:
Velina S. Atanasova, Crhistian de Jesus Cardona, Václav Hejret, Andreas Tiefenbacher, Theresia Mair, Loan Tran, Janette Pfneissl, Kristina Draganić, Carina Binder, Julijan Kabiljo, Janik Clement, Katharina Woeran, Barbara Neudert, Sabrina Wohlhaupter, Astrid Haase, Sandra Domazet, Markus Hengstschläger, Markus Mitterhauser, Leonhard Müllauer, Boris Tichý, Michael Bergmann, Gabriele Schweikert, Markus Hartl, Helmut Dolznig, Gerda Egger
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology, Vol 15, Iss 6, Pp 1391-1419 (2023)
Background & Aims: Patient-derived organoid cancer models are generated from epithelial tumor cells and reflect tumor characteristics. However, they lack the complexity of the tumor microenvironment, which is a key driver of tumorigenesis and therapy
Externí odkaz:
https://doaj.org/article/4731d5078fae4db69082355f0d4fbdc9
Autor:
Gordin Zupkovitz, Julijan Kabiljo, Michael Kothmayer, Katharina Schlick, Christian Schöfer, Sabine Lagger, Oliver Pusch
Publikováno v:
Frontiers in Molecular Biosciences, Vol 8 (2021)
Erosion of the epigenetic DNA methylation landscape is a widely recognized hallmark of aging. Emerging advances in high throughput sequencing techniques, in particular DNA methylation data analysis, have resulted in the establishment of precise human
Externí odkaz:
https://doaj.org/article/1ff5f76daab54cc8b316f2d69e3e5779
Autor:
Johannes Laengle, Julijan Kabiljo, Leah Hunter, Jakob Homola, Sophie Prodinger, Gerda Egger, Michael Bergmann
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
BackgroundThe monoclonal antibody (mAb) trastuzumab is part of the standard of care for patients with human epidermal growth factor receptor 2 (HER2)-overexpressing breast cancer. Antibody-dependent cell-mediated phagocytosis (ADCP) and cytotoxicity
Externí odkaz:
https://doaj.org/article/559ed2a59ebd432494c8e040ab974e7f
Autor:
Velina S Atanasova, Crhistian de Jesus Cardona, Vaclav Hejret, Andreas Tiefenbacher, Loan Tran, Carina Binder, Theresia Mair, Julijan Kabiljo, Janik Clement, Katharina Woeran, Barbara Neudert, Markus Hengstschläger, Markus Mitterhauser, Leonhard Müllauer, Boris Tichy, Michael Bergmann, Gabriele Schweikert, Markus Hartl, Helmut Dolznig, Gerda Egger
Patient-derived organoid (PDO) cancer models are generated from epithelial tumor cells. Although they reflect the molecular tumor characteristics, they lack the complexity of the tumor microenvironment, which is a key driver of tumorigenesis and ther
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7056150f57cf205623b4097a7bc3d202
https://doi.org/10.1101/2022.03.07.483214
https://doi.org/10.1101/2022.03.07.483214
Autor:
Loan Tran, Raheleh Sheibani Tezerji, Carlos Uziel Perez Malla, Anna Malzer, Ajna Logo, Katarina Misura, Theresia Mair, Thomas Dillinger, Madeleine Kuroll, Velina Atanasova, Julijan Kabiljo, Helga Schachner, Katharina Wöran, Judith Stift, Helmut Dolznig, Walter Pulverer, Michael Bergmann, Gerda Egger
Publikováno v:
Cancer Research. 82:A011-A011
Colorectal cancer (CRC) is a major cause of cancer-related deaths worldwide. Here, we established human patient-derived colorectal cancer organoid cultures (PDOs) to decipher the patient-specific DNA methylation profile and drug sensitivity towards 5
Autor:
Irene Kuehrer, Michael Bergmann, Katharina Wöran, F Herbst, Dietmar Tamandl, S Haegele, Joachim Widder, Judith Stift, F Laengle, P Razek, W Hulla, C Bitterman, M Herac, Rainer Schmid, B Dauser, M Monschein, Johannes Laengle, Dietmar Pils, Julijan Kabiljo
Publikováno v:
E-Poster Presentations.
Background Immune checkpoint inhibitors (ICI), such as ipilimumab (anti-cytotoxic T-lymphocyte-associated protein 4; CTLA-4) or nivolumab (anti-programmed cell death protein 1; PD-1) have been proven to be an effective strategy in solid cancers. Neve
Autor:
Michael Bergmann, Julijan Kabiljo, Irina Kuznetsova, S Prodinger, Monika Sachet, Andrej Egorov, Johannes Laengle, J. Homola
Publikováno v:
E-Poster Presentations.
Background Oncolytic viruses are becoming an integral part of immunological approaches to cancer treatment. Interleukin-2 (IL-2) is known to stimulate cytotoxic T-cells, and might therefore be a reasonable cargo to enhance the therapeutic effect of s
Autor:
Julijan Kabiljo, Jakob Homola, Sophie Prodinger, Michael Bergmann, Gerda Egger, Johannes Laengle, Leah Hunter
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
BackgroundThe monoclonal antibody (mAb) trastuzumab is part of the standard of care for patients with human epidermal growth factor receptor 2 (HER2)-overexpressing breast cancer. Antibody-dependent cell-mediated phagocytosis (ADCP) and cytotoxicity
Autor:
Dietmar Tamandl, Michael Bergmann, Dietmar Pils, Andreas L. Petzer, Julijan Kabiljo, Reinhold Fuegger, Judith Stift, Friedrich Laengle, Peter Razek, Bernhard Dauser, Johannes Laengle, Joachim Widder, Rainer Schmid, Wolfgang Huller, Clemens Bitterman, Hans Geinitz, Friedrich Herbst, Irene Kuehrer, Matthias Monschein, S. Haegele
Publikováno v:
Journal of Clinical Oncology. 39:TPS3623-TPS3623
TPS3623 Background: Immune checkpoint inhibitors (ICI), such as ipilimumab (anti-cytotoxic T-lymphocyte-associated protein 4) or nivolumab (anti-programmed cell death protein 1) have been proven to be an effective strategy in solid cancers. However,